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Long‑term bowel dysfunction 
following low anterior resection
Audrius Dulskas 1,2,3*, Povilas Kavaliauskas1, Lukas Pilipavicius4, Mantas Jodinskas4, 
Martynas Mikalonis5 & Narimantas E. Samalavicius3,6,7
Study aimed to assess long-term bowel function in patients who underwent low anterior resection 
for cancer five and more years ago. Patients who underwent low anterior resection for rectal cancer 
from 2010 to 2015 at National Cancer Institute were prospectively included in our study. They were 
interviewed using low anterior resection syndrome (LARS) score and Wexner questionnaire. We also 
assessed possible risk factors of postoperative bowel disorder. 150 patients were included in our 
study. Of them 125 (83.3%) were analysed. The median age at diagnosis was 62 years (40–79), and 
the average time of follow-up was 7.5 years (5–11). Overall, 58 (46.4%) patients had LARS, of them 
33 (26.4%)—major LARS and 25 (20%)—minor LARS and 67 (53.6%) reported no LARS. Wexner score 
results were: normal in 43 (34.4%) patients, minor faecal incontinence—55 (44%), average faecal 
incontinence—18 (14.4%), complete faecal incontinence—9 (7.2%). 51 patients (40.8%) had tumour in 
the upper third rectum, 51 (40.8%)—in the middle and 23 (18.4%)—lower third. Preoperative (chemo)
radiotherapy was the only significant risk factors for developing LARS in univariate analysis. Our study 
showed that only preoperative radiotherapy may be associated with more late problems in defecation 
after rectal cancer surgery.
Trial registration: NCT03920202.
Rectal cancer (RC) is a frequent and fatal disease with high incidence rate in developed countries, possibly 
because of differences in environment and  diet1. The age standardized incidence rate among men and women 
in Europe, was 15–25/100.000 new cases of RC per year with a range of mortality from four to 10/100.0002. For 
the last almost 30 years, the gold standard treatment for RC is low anterior resection (LAR) with total mesorectal 
excision (TME) as described by Heald3.
Unfortunately, up to 80% of patients undergoing LAR will suffer of bowel dysfunction including faecal 
urgency, frequent bowel movements, tenesmus or so called Low Anterior Resection Syndrome (LARS)4. Simply 
it has been defined as “disordered bowel function after rectal resection, leading to a detriment in quality of life”4. 
Same year LARS score was  developed5. This tool is easy to use and has been internationally and in Lithuania 
 validated6,7. Wexner score is another tool for evaluation of faecal  continence8. Recently Delphi consensus on 
LARS description was published. To meet the definition, a patient must have had an anterior resection (sphincter-
preserving rectal resection) and experience at least 1 of suggested 8 symptoms that result in at least one of sug-
gested 8  consequences9. The advantaged of the Delphi approach is that unlike most patient-reported outcome 
measures that were initially produced by expert clinician researchers who then consulted patient populations, the 
Delphi definition of LARS actively involved all major stakeholders, especially patients, early in the construction 
to ensure that the resulting tool was fit for purpose.
To our knowledge there are only five studies investigating long-term LARS following rectal surgery and influ-
ence it has on patients’ daily life using validated LARS  score10–14. These studies showed that LARS was found in 
47.5% to 90% of patients following rectal cancer surgery in long-term period.
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Our aim was to evaluate late functional results of patients who underwent rectal resection for rectal cancer. 
This included calculating LARS and Wexner score and identifying possible risk factors of late postoperative 
bowel disorders.
Materials and methods
Study population and data collection. National Cancer Institute review board approval was acquired. 
All patients gave written informed consent for participation in our study.
The trial was registered in ClinicalTrials.gov—NCT03920202.
Data was collected prospectively of patients who received surgical treatment for RC between 2010 and 2015 
at National Cancer institute in Vilnius, Lithuania. Between January to May 2020 all of the consented patients 
were interviewed face-to-face by same two interviewers in order to evaluate their bowel function outcomes using 
low anterior resection syndrome (LARS) score and Wexner score.
From 2010 through 2015, we prospectively identified a study population of 810 patients with biopsy-proven, 
rectal cancer without distant metastasis located up to 15 cm from anal verge and undergoing low anterior resec-
tion with partial (tumour in the upper 1/3 of the rectum—> 10 cm form the anal verge) or total mesorectal exci-
sion (if the tumour was in middle or lower 1/3 of the rectum—< 10 cm). Preoperative staging was performed 
based on a digital rectal examination, chest and abdominal computer tomography (CT) scan, pelvic magnetic 
resonance imaging (MRI) and colonoscopy with a biopsy. If patients was diagnosed with T3, 4N+ disease, they 
underwent long-course chemoradiotherapy (45 Gy given in 25 fractions over 5 weeks with adding in week one 
and week five 5-fluoropyrimidine-based chemotherapy), if it was < T3N0 or T2N+ tumour—upfront surgery. 
If the patient underwent preoperative chemoradiotherapy, low anterior resesction with anastomosis, he was a 
candidate for a protective ileostomy. All patients underwent open rectal resection with high inferior mesenteric 
artery (AMI) and inferior mesenteric vein (VMI) ligation with mobilization of splenic flexure. Circular anasto-
mosis with end-to-end or side-to-end was performed. Of them 660 patients were excluded due to the exclusion 
criteria: dead patients (320), the patients underwent Hartman’s procedure or abdominoperineal excision (300), 
declined to participate (40). Of them, we included 150. 125 (83.3%) patients filled the questionnaires and were 
included in final analysis (20 were impossible to contact, five had permanent stoma). Possible risk factors: sex, age, 
tumour height (upper 1/3 vs middle 1/3 vs lower 1/3), type of anastomosis (side-to-end vs endo-to-end), post-
operative course (with complications vs no complications), size of the tumour (according to T stage), presence 
of temporary ileostomy after the surgery (yes vs no), neoadjuvant treatment, nodular involvement, anastomotic 
diameter (according to circular stapler used) were assessed.
Questionnaires. LARS score is a tool consisting of five items, which are as follows: incontinence due to 
flatus (score range from 0 to 7), incontinence due to liquid stools (score range from 0 to 3), frequency of bowel 
movements (score range from 0 to 5), clustering (score range from 0 to 11) and urgency (score range from 0 to 
16). The severity of each item is calculated on a scale ranging from 0 to 42, with a score of 0–20 (no LARS), 21–29 
(minor LARS) and 30–42 (major LARS).
Wexner score also consists of five items, which are as follows: solid incontinence (score range from 0 to 4), 
liquid incontinence (score range from 0 to 4), gas incontinence (score range from 0 to 4), pad wearing (score 
range from 0 to 4) and lifestyle alteration (score range from 0 to 4). The severity of each item was calculated on 
a scale ranging from 0 to 20. With a score of 0 (normal), 1–8 (minor faecal incontinence), 9–14 (average faecal 
incontinence) and 15–20 (complete faecal incontinence).
Statistical analysis. For basic characteristics, we used descriptive statistics. Chi-square and student T-test 
were used to compare between groups or means. Univariate and multivariate logistic regression analysis.
was used to evaluate the odds ratio (OR) with the corresponding 95% confidence interval.
(CI). In order to examine age as a risk factor, patients were divided into two groups: group 1 (< = 62 years), 
consisting of 45 patients, and group 2 (> 62 years) as 62 was the median age. To compare two different question-
naires we used Spearman correlation index (rs). It can take values from + 1 to − 1. A rs of + 1 indicates a perfect 
association of ranks, a rs of zero indicates no association between ranks and a rs of − 1 indicates a perfect negative 
association of ranks. The closer rs is to zero, the weaker the association between the ranks.
Data was entered in Microsoft Office Excel 2013, calculated and analysed in IBM SPSS Statistics 23.0 (IBM 
Corp., Armonk, NY, USA). A p value < 0.05 was considered statistically significant.
Conference presentation. The study was presented as a poster at International Society of Surgeons con-
ference in Krakow, Poland August 11–15, 2019 and ESCP annual meeting Vienna, Austria September 25–27, 
2019.
Ethical approval. All procedures involving human participants were performed in accordance with the eth-
ical standards of the institutional and/or national research committee and the 1964 Declaration of Helsinki and 
its later amendments or comparable ethical standards. This article does not contain any studies using animals.
Results
Between 2010 and 2015, 810 patients underwent radical resection for rectal cancer at the National Cancer Insti-
tute in Vilnius. Of them 125 patients were included in our study (Fig. 1). Among this group, 64 (51.2%) were men 
and 61 (48.8%) were women (Table 1). The median age during operation was 69 years (45–88), and the average 
time of follow-up in the responders was 7.5 years (5–11). Overall, 58 (46.4%) patients had LARS, of them33 
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(26.4%)—major LARS and 25 (20%)—minor LARS and 67 (56.6%) reported no LARS. Wexner score results 
were normal in 43 (34.4%) patients, minor faecal incontinence—55 (44%), average faecal incontinence—18 
(14.4%), complete faecal incontinence—9 (7.2%). 51 patients (40.8%) had tumour in the upper third rectum, 51 
(40.8%)—in the middle part and 23 (19.40%)—lower third. 35 (28%) patients received preoperative radiotherapy 
and 13 patients (10.4%)—chemoradiotherapy. Further descriptive statistics are shown in Table 1.
Univariate analysis showed that only neoadjuvant treatment was associated with Major LARS prevalence 
(Table 2). Univariate analysis for average and total faecal incontinence did not show any significant risk factors.
Spearman correlation showed a strong relationship between LARS score and Wexner score—r = 0,723 
(p < 0.000).
Discussion
In this study, we found that less than half of the patients (46.4%) reported LARS symptoms and 26.4% of them 
had major LARS. Three-fourths (76.4%) had no or had only minor faecal incontinence according to Wexner 
score. The average time of follow-up was 7.5 years, so in our opinion results are quite satisfactory. However, one-
fourth (26.4%) of the patients had major LARS score and nine (7.2%) patients had complete faecal incontinence 
according to Wexner score. In searching for possible risk factors associated with higher LARS and Wexner scores, 
we identified that patients who received preoperative chemoradiotherapy, were more likely to have a higher 
LARS score. Relatively lower prevalence of LARS compared to other studies might be related to lower number 
of patients undergoing preoperative chemoradiotherapy (90–72%) and higher number of patients with upper 
third rectal cancer (51–40.8%).
Comparing our results to previous studies (Table 3) worst results are seen in Beppu et al.  study10. Differently 
from us authors included only patients with low rectal cancer after chemoradiotherapy. 78 of 87 (90%) patients 
experienced LARS. Chen et al. in their study showed that major LARS was present in 46% of patients 15 years 
following the surgery, and major LARS was associated with reduced quality of  life11. Authors found only two risk 
factors for major LARS: preoperative chemoradiotherapy and age < 75 years. Meanwhile Sturiale et al. followed 
the patients for average 13.7 years. They reported LARS in 44 patients (47.5%), with major manifestations in 19 
patients (20.5%), and minor symptoms in 25 patients (27%). Age more than 70 years, tumour distance from the 
external anal verge, neoadjuvant treatment, and interval time of closing stoma were independent prognostic fac-
tors of functional disorders after  surgery12. Other possible risk factors, such as gender, and interestingly tumour 
height or presence of the ileostomy did not reveal any significant impact on LARS or Wexner scores. Differently 
from our study, Gadan et al. did show the long-term negative effect of ileostomy formation on bowel  function13. 
Similarly to our study, Pienowski et al. found in a long-term preoperative chemoradiotherapy, younger age and 
low level of the tumour were the risk factors of having LARS, and having major  LARS14.
It might seem that studies assessing the long-term bowel dysfunction is a very new insight. Actually, we 
purposely have discussed only the studies with certain tools used to assess bowel dysfunction. All these studies 
used LARS score to assess the LARS following the surgery. Some historical studies from late nineties also assessed 
bowel function changes following rectal cancer  surgery15–18. Hida et al. from Japan conducted a prospective 
study including 46 patients who underwent J-pouch reconstruction (J-group) and 49 patients who underwent 
straight anastomosis (S-group) after LAR for rectal  cancer15. The assessed the bowel function using a 17-item 
questionnaire and mano-volumetry. They found that the number of bowel movements during the day (≥ 5, 4.3 vs. 
Figure 1.  Consort flow diagram of the study.
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29.2 percent; P = 0.028) and at night (> 1/week, 4.3 vs. 33.3 percent; P = 0.013) and urgency (4.3 vs. 33.3 percent; 
P = 0.013) and soiling (21.7 vs. 50.0 percent; P = 0.043) were less in the J-group than in the S-group. Dehni et al. 
also assessed long-term bowel function comparing same two techniques for anastomosis (J-pouch vs straight 
anastomosis) in 81  patients16. The average time following the surgery was 5 years. Patients with colonic J-pouch-
anal anastomosis had better function in terms of frequency of defecation (1.57 + 1 vs. 2.79 ±  1; P = 0.001) and 
presence of irregular transit or stool "clustering" (30 vs. 71 percent; P = 0.003). The patients with J-pouch also 
had less repeative need to defecate again within one hour. However, it is impossible to assess percentage of bowel 
dysfunction from the whole number of patients. It is seen that up to 70–80% of patients included in the study 
had some degree of bowel dysfunction. Differently from studies mentioned above, Floodeen et al. assessed a 
total of 123 patients who underwent low anterior resection and had protective ileostomy (stoma group) and had 
no ileostomy (no-stoma group)17. They contacted the patients 5 years following the surgery and filled the bowel 
function questionnaire with 10 questions (65 in the no-stoma group and 58 in the stoma group). Daytime stool 
Table 1.  Characteristics of the patients included in our study.
Variables Number, n (%)
No LARS 67 (53.65%)
Minor LARS 25 (20%)
Major LARS 33 (26.4%)
Wexner score
Normal 43 (34.4%)
Minor faecal incontinence 55 (44%)
Average faecal incontinence 18 (14.4%)







Part of rectum affected
Upper 1/3 51 (40.8%)
Middle 1/3 51 (40.8%)





End to end 15 (12%)
Side to end 91 (72.8%)










Postoperative complications (Clavien Dindo classification)
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frequency at 5-year follow-up was a median 2.5 in the no-stoma group and 3.0 in the stoma group, and one third 
of the patients in both groups could not defer defecation for ≥ 15 min. Regarding the need for medication to open 
the bowel, evacuation difficulties, fragmentation of bowel movements, and incontinence, there were no differ-
ences between the 2 groups. Wagman et al. assessed 35 patients undergoing radiation and surgery with coloanal 
anastomosis using simple scale for long-term sphincter  function18. The median follow-up was 56 months [range 
4–121 months]. Sphincter function was excellent in 59%, good in 26%, fair in 15%, and none had poor func-
tion. Therefore, 85% (23) of the 27 evaluable patients had good or excellent sphincter function. All patients had 
Table 2.  Univariate analysis of risk factors for major low anterior resection syndrome (LARS).
Factor ODDS ration P 95% CI
Gender
Male 1 0.442 0.62–3.04
Female 1.37
Part of rectum affected
Upper 1/3 0.4 0.13–1.23
Middle 1/3 0.86 0.165
Lower 1/3 1
Age
< 62 years 0.52 0.117 0.23–1.18
> 62 years 1
Overal postoperative complications
No 0.97 0.95 0.37–2.56
Yes 1
Overall comorbidities
No 1.3 0.522 0.58–2.9
Yes 1
Type of anastomosis
End to end 2.37 0.64–8.8
No data 2.89 0.165 0.6–13.6








Yes 1.74 0.21 0.73–4.02
No 1
Preventive ileostomy
Yes 1 0.065 0.93–11.95
No 3.33
Neoadjuvant therapy
Yes 2.82 0.016 1.22–6.53
No 1
Table 3.  Previous studies on long-term low anterior resection syndrome (LARS) incidence.
Refernces Number of patients included Institution
Incidence of long-term LARS 
n, (%) Time following the surgery (y)
Beppu et al.10 87 Single centre 78 (90) 6.5
Chen et al.11 241 Multi centre 164 (68) 14.6
Sturiale et al.12 93 Two centres 44 (47.5) 13.7
Gadan et al.13 87 Multi centre 63 (72) 12
Pieniowski et al.14 282 Multi centre 237 (73) > 5
Our results 125 Single centre 30 (44.77) 7.5
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complete continence of solid stool. Although minor soiling (40%) and difficulty with evacuation were common 
(50%), these problems were well tolerated.
These studies obviously gives information on long-term bowel function, but lack of using same validated 
questionnaires is a major limitation. Another drawback is the inclusion of studies with the specific primary 
outcomes (comparative studies of two techniques) and not describing a real world data.
We have to take into account that 25 patients from the primary list were excluded due to various reasons 
which lead to decreased number of patients in our study (from, the response rate was %) and this could be seen 
as one of the drawbacks of this study. In addition, a correlation between postoperative LARS and Wexner scores 
was found. It seems LARS and Wexner scores can be used together to evaluate the patients more broadly than 
with LARS alone.
Our studies has some strengths. First, it uses two most often met scores for bowel function assessment in 
patients following rectal surgery and assesses the correlation. Secondly, we have more than 120 patients—high-
est number from the single centre so far. Another strength of our study—we are presenting the highest number 
of patients included from the single institution base and not from other clinical  trial11,13—the real world data 
presented. The greatest strength of this study is the response rate of more than 90% in those who the question-
naires was shown to.
Our study has other limitations also. First, small sample size and the risk of possible type 2 error—there is 
always a possibility that those patients who were not included in the study died or did not want to participate 
had worse functional outcome and only those with better function answered the questions. Second, we did not 
perform the longitudinal assessment of bowel symptoms within the period. Lastly, our study was restricted to 
the patients from single centre, including only small number from all treated rectal cancer patients. However, 
our institution is the tertiary referral cancer centre and performs more than 40% of all LARs in Lithuania.
To conclude, our study shows that LARS symptoms last many years after the surgery. Furthermore, our results 
show that bowel dysfunction, is a chronic condition and the patient will need support and treatment over a long 
time. This knowledge is important in discussions with patients (especially older patients with already affected 
bowel function) with severe LARS symptoms who may prefer a permanent stoma. Further studies are needed to 
increase the prevention of LARS, improve treatment and to find best support of patients with LARS.
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